Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Rhea-AI Summary
Teleflex (NYSE:TFX) announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The presentation is scheduled for Tuesday, September 9, 2025, at 3:20 p.m. ET at the Sheraton New York Times Square. Investors can access the live audio webcast through the company's investor relations website at teleflex.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TFX declined 0.24%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
WAYNE, Pa., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference at the Sheraton New York Times Square, on Tuesday, September 9, 2025, at 3:20 p.m. (ET).
A live audio webcast of the conference presentation will be available on the investor section of the Teleflex website at teleflex.com.
About Teleflex Incorporated
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare.
Teleflex is the home of Arrow™, Barrigel™, Deknatel™, QuikClot™, LMA™, Pilling™, Rüsch™, UroLift™ and Weck™ – trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com.
Contacts:
Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
investor.relations@teleflex.com
610-948-2836